Publications
2024
Gene Expression Dysregulation in Whole Blood of Patients with Clostridioides difficile Infection
Tsakiroglou, M., Evans, A., Doce-Carracedo, A., Little, M., Hornby, R., Roberts, P., . . . Pirmohamed, M. (n.d.). Gene Expression Dysregulation in Whole Blood of Patients with Clostridioides difficile Infection. International Journal of Molecular Sciences, 25(23), 12653. doi:10.3390/ijms252312653
Data from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Data from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.c.7451265
Data from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Data from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.c.7451265.v1
Figure S1 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S1 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024180
Figure S1 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S1 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024180.v1
Figure S10 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S10 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024177
Figure S10 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S10 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024177.v1
Figure S11 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S11 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024174.v1
Figure S11 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S11 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024174
Figure S12 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S12 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024171.v1
Figure S12 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S12 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024171
Figure S2 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S2 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024168.v1
Figure S2 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S2 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024168
Figure S3 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S3 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024162.v1
Figure S3 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S3 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024162
Figure S4 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S4 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024159
Figure S4 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S4 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024159.v1
Figure S5 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S5 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024156
Figure S5 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S5 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024156.v1
Figure S6 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S6 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024153
Figure S6 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S6 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024153.v1
Figure S7 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S7 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024150
Figure S7 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S7 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024150.v1
Figure S8 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S8 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024147
Figure S8 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S8 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024147.v1
Figure S9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024144.v1
Figure S9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Figure S9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024144
Supplemental material from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Supplemental material from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024141
Supplemental material from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Supplemental material from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024141.v1
Supplementary Tables 1-9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Supplementary Tables 1-9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024138.v1
Supplementary Tables 1-9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Supplementary Tables 1-9 from Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. doi:10.1158/0008-5472.27024138
P06-10 NGS-based discovery of circulating microRNA biomarkers of drug-induced pancreatic injury (DIPI)
Szatmary, P., Evans, A., Jones, A., Latawiec, D., Cai, W., Kattakayam, A., . . . Sutton, R. (2024). P06-10 NGS-based discovery of circulating microRNA biomarkers of drug-induced pancreatic injury (DIPI). Toxicology Letters, 399, S155-S156. doi:10.1016/j.toxlet.2024.07.394
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.
Bermejo-Rodriguez, C., Araos Henríquez, J., Caligiuri, G., Pinto Teles, S., Park, Y., Evans, A., . . . Perez-Mancera, P. A. (2024). Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.. Cancer research. doi:10.1158/0008-5472.can-23-3419
2023
K-Ras independence due to N-Ras expression in cancer cell lines giving resistance to K-Ras specific inhibitors
Ferguson, R., Aughton, K., Evans, A., Shaw, V., Costello, E., & Greenhalf, W. (2023). K-Ras independence due to N-Ras expression in cancer cell lines giving resistance to K-Ras specific inhibitors. Pancreatology, 23, e149. doi:10.1016/j.pan.2023.06.783
Sodium valproate causes pancreatic injury in vitro and in vivo via dysregulation of one carbon metabolism
Cai, W., Chvanov, M., Awais, M., Meng, X., Latawiec, D., Brown, J., . . . Sutton, R. (2023). Sodium valproate causes pancreatic injury in vitro and in vivo via dysregulation of one carbon metabolism. Pancreatology, 23, e20-e21. doi:10.1016/j.pan.2023.06.453
Transcriptomic profiling reveals molecular and inflammatory gene signatures of acute pancreatitis in cyclophilin D knockout and wild-type murine blood
Wu, D., Mukherjee, R., Armstrong, J., Wen, L., Sud, A., Latawiec, D., . . . Sutton, R. (2023). Transcriptomic profiling reveals molecular and inflammatory gene signatures of acute pancreatitis in cyclophilin D knockout and wild-type murine blood. Pancreatology, 23, e67. doi:10.1016/j.pan.2023.06.573
Leukocyte gene expression profiles in fatty acid ethyl ester-induced acute pancreatitis
Wu, D., Mukherjee, R., Armstrong, J., Wen, L., Sud, A., Latawiec, D., . . . Sutton, R. (2023). Leukocyte gene expression profiles in fatty acid ethyl ester-induced acute pancreatitis. In BRITISH JOURNAL OF SURGERY Vol. 110 (pp. III5). doi:10.1093/bjs/znad101.016
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
Ferguson, R., Aughton, K., Evans, A., Shaw, V., Armstrong, J., Ware, A., . . . Greenhalf, W. (2023). Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation. CURRENT ISSUES IN MOLECULAR BIOLOGY, 45(3), 2505-2520. doi:10.3390/cimb45030164
Wild-type N-Ras Complements Mutant K-Ras in Pancreatic Cancer Cell Lines but K-Ras has a Specific Role in Cell Cycle Independent Regulation of G2 Cyclins
Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis
Tsakiroglou, M., Evans, A., & Pirmohamed, M. (2023). Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis. FRONTIERS IN GENETICS, 14. doi:10.3389/fgene.2023.1100352
2022
Pancreatic cancer-related diabetes mellitus: a clinical perspective
Stott, M., Oldfield, L., Evans, A., Halloran, C., & Costello, E. (2022). Pancreatic cancer-related diabetes mellitus: a clinical perspective. Pancreatology, 22, e63. doi:10.1016/j.pan.2022.06.164
The Effect of Sampling Methodology upon Pancreatic Cancer Microbiome Communities
Hale, J., Evans, A., Lilley, A., Fine, D., Costello-Goldring, E., Halloran, C., . . . Greenhalf, W. (2022). The Effect of Sampling Methodology upon Pancreatic Cancer Microbiome Communities. Pancreatology, 22, e61. doi:10.1016/j.pan.2022.06.157
Wild-type N-Ras Complements Mutant K-Ras in Pancreatic Cancer Cell Lines but K-Ras has a Specific Role in Cell Cycle Independent Regulation of G2 Cyclins
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes
Oldfield, L., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T., Psarelli, E. E., . . . Costello, E. (2022). Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBIOMEDICINE, 75. doi:10.1016/j.ebiom.2021.103802
2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
Aughton, K., Elander, N. O., Evans, A., Jackson, R., Campbell, F., Costello, E., . . . Greenhalf, W. (2021). hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. CANCERS, 13(22). doi:10.3390/cancers13225758
The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer
Patel, C., Williams, D., Gana, T., Evans, A., Jackson, R., Campbell, F., . . . Costello, E. (2021). The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer. Pancreatology, 21, S69-S70. doi:10.1016/j.pan.2021.05.186
The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements
Ashworth, M., Small, B., Oldfield, L., Evans, A., Greenhalf, W., Halloran, C., & Costello, E. (2021). The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-85052-5
2020
UK–EDI: Detecting Pancreatic Cancer with DM
Oldfield, L., Rao, R. G., Jenkinson, C., Evans, A., Purewal, T., Psarelli, E. E., . . . Costello, E. (2020). UK–EDI: Detecting Pancreatic Cancer with DM. Pancreatology, 20(8), e14. doi:10.1016/j.pan.2020.10.003
Enrichment of circulating tumour cells by dielectrophoresis in pancreatic ductal adenocarcinoma
Evans, A., Jones, C., Hale, J., Martin, S., Rawcliffe, C., Costello, E., . . . Greenhalf, W. (2020). Enrichment of circulating tumour cells by dielectrophoresis in pancreatic ductal adenocarcinoma. Pancreatology, 20, S131. doi:10.1016/j.pan.2020.07.242
Investigation of detaching cells as a potential in vitro model of epithelial–mesenchymal transition in a metastatic pancreatic cancer cell line
Hale, J., Evans, A., Al-Selwi, Y., Costello, E., Slupsky, J., Palmer, D., & Greenhalf, W. (2020). Investigation of detaching cells as a potential in vitro model of epithelial–mesenchymal transition in a metastatic pancreatic cancer cell line. Pancreatology, 20, S134-S135. doi:10.1016/j.pan.2020.07.251
Prevalence of diabetes mellitus among individuals undergoing pancreatic surgery
Crosby, B., Oldfield, L., Rao, R., Evans, A., Ghaneh, P., Hale, J., . . . Costello, E. (2020). Prevalence of diabetes mellitus among individuals undergoing pancreatic surgery. Pancreatology, 20, S101. doi:10.1016/j.pan.2020.07.172
Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for Protein Biomarkers
Oldfield, L., Barrera, L., Williams, D., Evans, A. E., Neoptolemos, J., & Costello, E. (2020). Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for Protein Biomarkers. In Molecular and Translational Medicine (pp. 73-82). Springer International Publishing. doi:10.1007/978-3-030-49476-6_4
Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.
Barrera, L. N., Evans, A., Lane, B., Brumskill, S., Oldfield, F. E., Campbell, F., . . . Costello, E. (2020). Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.. Cancer Research, 80(13), 2861-2873. doi:10.1158/0008-5472.can-19-3534
2019
PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts
Barrera, L. N., Evans, A., Lane, B., Brumskill, S., Oldfield, F., Campbell, F., . . . Costello, E. (2019). PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts. Pancreatology, 19, S158. doi:10.1016/j.pan.2019.05.423
The human equilibrative nucleoside transporter1 evaluated by SP120 and 10D7G2 had the potential to predict the prognosis in the patients with pancreatic cancer treated with adjuvant gemcitabine: Collaborative study of the JASPAC 01 trial
Okamura, Y., Yasukawa, S., Narimatsu, H., Evans, A., Boku, N., Fukutomi, A., . . . Uesaka, K. (2019). The human equilibrative nucleoside transporter1 evaluated by SP120 and 10D7G2 had the potential to predict the prognosis in the patients with pancreatic cancer treated with adjuvant gemcitabine: Collaborative study of the JASPAC 01 trial. Pancreatology, 19, S106. doi:10.1016/j.pan.2019.05.282
2018
S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes
Nedjadi, T., Evans, A., Sheikh, A., Barerra, L., Al-Ghamdi, S., Oldfield, L., . . . Costello, E. (2018). S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes. BMC CANCER, 18. doi:10.1186/s12885-018-5161-4
F<sub>1</sub>F<sub>0</sub>-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation
Tanton, H., Voronina, S., Evans, A., Armstrong, J., Sutton, R., Criddle, D. N., . . . Tepikin, A. V. (2018). F<sub>1</sub>F<sub>0</sub>-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation. FRONTIERS IN PHYSIOLOGY, 9. doi:10.3389/fphys.2018.00833
Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or metastatic pancreatic carcinoma
Evans, A., Jackson, R., Shaw, V. E., Ghaneh, P., Wadsley, J., Valle, J. W., . . . Middleton, G. (2018). Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or metastatic pancreatic carcinoma. Pancreatology, 18(4), S127-S128. doi:10.1016/j.pan.2018.05.343
Different mechanisms of gemcitabine resistance in Suit-2 cell lines and double stranded DNA Breaks
Mann, K., Chatzipavli, V., Evans, A., Costello, E., Palmer, D., Ghaneh, P., . . . Greenhalf, W. (2018). Different mechanisms of gemcitabine resistance in Suit-2 cell lines and double stranded DNA Breaks. Pancreatology, 18(4), S144. doi:10.1016/j.pan.2018.05.388
Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile
Barrera, L., Evans, A., Lane, B., Brumskill, S., Oldfield, F., Campbell, F., . . . Costello, E. (2018). Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile. Pancreatology, 18(4), S94. doi:10.1016/j.pan.2018.05.254
2017
Comparative bioenergetics of pancreatic acinar cells and pancreatic cancer cells
Tanton, H., Voronia, S., Evans, A., Costello, E., & Tepikin, A. (2017). Comparative bioenergetics of pancreatic acinar cells and pancreatic cancer cells. Pancreatology, 17(3), S12-S13. doi:10.1016/j.pan.2017.05.040
Cytokines as potential biomarkers for distinguishing patients with pancreatic cancer and type 2 diabetes mellitus
Rao, R. G., Oldfield, L., Evans, A., Sivapalan, L., Schuler, P., Purewal, T., . . . Costello, E. (2017). Cytokines as potential biomarkers for distinguishing patients with pancreatic cancer and type 2 diabetes mellitus. Pancreatology, 17(3), S33. doi:10.1016/j.pan.2017.05.103
Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.
Neoptolemos, J. P., Palmer, D., Greenhalf, W., Ghaneh, P., Jackson, R., Evans, A., . . . Middleton, G. W. (2017). Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35. doi:10.1200/JCO.2017.35.15_suppl.4104
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Middleton, G., Palmer, D. H., Greenhalf, W., Ghaneh, P., Jackson, R., Cox, T., . . . Neoptolemos, J. P. (2017). Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18(4), 486-499. doi:10.1016/S1470-2045(17)30084-0
2016
Circulating tenascin C levels distinguish pancreatic cancer from chronic pancreatitis and correlate with pancreatic stromal expression
Evans, A., Jenkinson, C., Barrera, L., Oldfield, F., Rimmer, N., Garner, E., . . . Costello, E. (2016). Circulating tenascin C levels distinguish pancreatic cancer from chronic pancreatitis and correlate with pancreatic stromal expression. Pancreatology, 16(3), S30-S31. doi:10.1016/j.pan.2016.05.105
Combined analysis of cytidine deaminase mRNA transcript expression with hENT1 protein expression on tissue microarrays from the ESPAC-3 trial helps predict patient survival with gemcitabine treatment
Aughton, K., Elander, N., Palmer, D., Cox, T., Campbell, F., Garner, E., . . . Greenhalf, W. (2016). Combined analysis of cytidine deaminase mRNA transcript expression with hENT1 protein expression on tissue microarrays from the ESPAC-3 trial helps predict patient survival with gemcitabine treatment. Pancreatology, 16(3), S30. doi:10.1016/j.pan.2016.05.104
Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus
Jenkinson, C., Elliott, V., Evans, A., Oldfield, L., Jenkins, R., O'Brien, D., . . . Costello-Goldring, E. (2016). Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus. Clinical Cancer Research, 22(7), 1734-1743. doi:10.1158/1078-0432.ccr-15-0879
2015
Decreased serum thrombospondin-1 levels in pancreatic ductal adenocarcinoma patients: an early indicator of disease or diabetes mellitus development?
Jenkinson, C., Elliott, V., Evans, A., Oldfield, L., O'Brien, D., Apostolidou, S., . . . Costello, E. (2015). Decreased serum thrombospondin-1 levels in pancreatic ductal adenocarcinoma patients: an early indicator of disease or diabetes mellitus development?. Pancreatology, 15(3), S28. doi:10.1016/j.pan.2015.05.129
Evaluation of stromal quantification in pancreatic ductal adenocarcinoma using a tissue microarray
Evans, A., Oldfield, F., Hand, K., Halloran, C., Campbell, F., Neoptolemos, J., . . . Costello, E. (2015). Evaluation of stromal quantification in pancreatic ductal adenocarcinoma using a tissue microarray. Pancreatology, 15(3), S22. doi:10.1016/j.pan.2015.05.112
Cytidine Deaminase (CDA) Transcript Analysis Complements hENT1 Protein Staining in Predicting Gemcitabine Response in the ESPAC-3 Pancreatic Cancer Cohort
Elander, N., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Costello, E., Palmer, D., . . . Greenhalf, W. (2015). Cytidine Deaminase (CDA) Transcript Analysis Complements hENT1 Protein Staining in Predicting Gemcitabine Response in the ESPAC-3 Pancreatic Cancer Cohort. PANCREAS, 44(8), 1371. Retrieved from https://www.webofscience.com/
2014
Circulatory biomarkers for the differential diagnosis of pancreatic cancer and chronic pancreatitis
Evans, A., Jenkinson, C., Greenhalf, W., Neoptolemos, J., & Costello, E. (2014). Circulatory biomarkers for the differential diagnosis of pancreatic cancer and chronic pancreatitis. Pancreatology, 14(3), S102-S103. doi:10.1016/j.pan.2014.05.727
2012
The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
Evans, A., & Costello, E. (2012). The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. FRONTIERS IN PHYSIOLOGY, 3. doi:10.3389/fphys.2012.00270